The outbreak of COVID-19: An overview

Yi-Chi Wu, Ching-Sung Chen, Yu-Jiun Chan, Yi-Chi Wu, Ching-Sung Chen, Yu-Jiun Chan

Abstract

In late December 2019, a previous unidentified coronavirus, currently named as the 2019 novel coronavirus#, emerged from Wuhan, China, and resulted in a formidable outbreak in many cities in China and expanded globally, including Thailand, Republic of Korea, Japan, United States, Philippines, Viet Nam, and our country (as of 2/6/2020 at least 25 countries). The disease is officially named as Coronavirus Disease-2019 (COVID-19, by WHO on February 11, 2020). It is also named as Severe Pneumonia with Novel Pathogens on January 15, 2019 by the Taiwan CDC, the Ministry of Health and is a notifiable communicable disease of the fifth category. COVID-19 is a potential zoonotic disease with low to moderate (estimated 2%-5%) mortality rate. Person-to-person transmission may occur through droplet or contact transmission and if there is a lack of stringent infection control or if no proper personal protective equipment available, it may jeopardize the first-line healthcare workers. Currently, there is no definite treatment for COVID-19 although some drugs are under investigation. To promptly identify patients and prevent further spreading, physicians should be aware of the travel or contact history of the patient with compatible symptoms.

Conflict of interest statement

Conflicts of interest: The authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article

References

    1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 DOI: 10.1016/S0140-6736(20)30183-5.
    1. World Health Organization. Novel Coronavirus (2019-nCoV) Available at . Accessed February 7, 2020.
    1. World Health Organization. 2019-nCoV Situation Report. /. Accessed February 7, 2020.
    1. Ron A. M. Fouchier, Thijs Kuiken, Martin Schutten, Geert van Amerongen1, Gerard J, et al. Koch’s postulates fulfilled for SARS virus. Nature. 2003;423:240.
    1. Perlman S. Another decade, another coronavirus. N Engl J Med. 2020 DOI: 10.1056/NEJMe2001126.
    1. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, et al. ; HKU/UCH SARS Study Group Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 20033611767–72
    1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 20123671814–20
    1. Chan Jasper FW, Yuan S, Kok KH, To Kelvin KW, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 DOI: .
    1. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020 DOI: 10.1056/NEJMoa2001191.
    1. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020 DOI: 10.1056/NEJMc2001468.
    1. Pgab LT, Nguyen TV, Luong QC, Nguyen TV, Nguyen HY, Le HQ, et al. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med. 2020 DOI: 10.1056/NEJMc2001272.
    1. Taiwan Centers for Disease Control. Severe Special Infectious Pneumonia. Available at . Accessed February 7, 2020.
    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020 DOI: 10.1056/NEJMoa2001017.
    1. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020 DOI: 10.1016/S0140-6736(20)30251.
    1. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. N Engl J Med. 2020 DOI: 10.1016/S0140-6736(20)30211-7.
    1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020 DOI: 10.1056/NEJMoa200131.
    1. Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol. 2020 DOI: 10.1002/jmv.25689.
    1. Munster VJ, Koopmans M, Doremalen NV, Riel DV, Wit ED. A novel coronavirus emerging in China – Key Questions for Impact Assessment. N Engl J Med. 2020 DOI: 10.1056/NEJMp2000929.
    1. Mo Y, Fisher D. A review of treatment modalities for middle east respiratory syndrome. J Antimicrob Chemother 2016713340–50
    1. Chu CM, Cheng VC, Hung IF, Wong MM, Chan KH, Chan KS, et al. ; HKU/UCH SARS Study Group Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 200459252–6
    1. Pradhan P, Pandey AK, Mishra A, Gupta P, Tripathi PK, Menon MB, et al. Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag. bioRxiv. 2020 Available at . Accessed February 7, 2020. (withdrawn)
    1. National Environment Agency. Interim Guidelines for Environmental Cleaning and Disinfection of Areas Exposed to Confirmed Case(s) of 2019 Novel Coronavirus (2019-nCoV) in Non-Healthcare Commercial Premises. Available at . Accessed February 7, 2020.
    1. World Health Organization. Hand Hygiene for Health Workers Caring for Ebola Patients. Available at . Accessed February 7, 2020.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever